ClinicalTrials.govpublic full text
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
ovarian neoplasm epithelial, ovarian cancer, fallopian tube neoplasms, peritoneal carcinoma, ovarian serous adenocarcinoma, phase 2, oregovomab, chemoimmunotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 813591
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.